It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ménière disease (MD), an idiopathic disorder of sensorineural hearing loss and vertigo, shares many similarities with two common skin conditions, atopic dermatitis (AD) and vitiligo. Recent studies have suggested that MD may be related to or triggered by autoimmune conditions, notably Hashimoto thyroiditis and alopecia areata. These evidences led to the authors contemplating the possibility of immunological bridge between MD and the two skin conditions. The authors have tested this hypothesis with population-based cohort from the National Health Insurance Service Database of Korea. A cohort of 1.1 million patients was extracted from the database. Using χ2 tests, prevalence of the two skin disorders in relation to MD status was analysed. In MD patients, the odds ratios for having concurrent AD and vitiligo were 0.717 (95% CI, 0.535–0.962, p = 0.026) and 2.149 (95% CI, 1.396–3.308, p = 0.001), respectively. Females and older patients were more than twice likely to be affected by the two skin conditions. The relationship between vitiligo and MD was significant in younger subgroup only. Socio-economic subgroup analysis revealed the observed patterns are primarily a middle-upper class phenomenon. Uncertainty regarding temporal sequence of onset, and lack of detail on disease severity and subtype kept the study from more refined conclusion. In concluding, AD and vitiligo might be linked to MD through Treg-driven action of cellular immunity, but further big data-based investigations must follow.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Konyang University, Department of Dermatology, College of Medicine, Daejeon, Republic of Korea (GRID:grid.411143.2) (ISNI:0000 0000 8674 9741); Konyang University, Myunggok Medical Research Institute, College of Medicine, Daejeon, Republic of Korea (GRID:grid.411143.2) (ISNI:0000 0000 8674 9741)
2 Catholic University of Daegu, School of Medicine, Department of Medical Statistics, Gyeongsan, South Korea (GRID:grid.253755.3) (ISNI:0000 0000 9370 7312)
3 Hallym University College of Medicine, Department of Otorhinolaryngology-Head and Neck Surgery, Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea (GRID:grid.256753.0) (ISNI:0000 0004 0470 5964); Hallym University College of Medicine, Institute of New Frontier Research, Chuncheon, Republic of Korea (GRID:grid.256753.0) (ISNI:0000 0004 0470 5964)
4 College of Medicine, Konyang University, Department of Otorhinolaryngology–Head and Neck Surgery, Daejeon, Republic of Korea (GRID:grid.411143.2) (ISNI:0000 0000 8674 9741); Konyang University, Department of Biomedical Informatics, College of Medicine, Daejeon, Republic of Korea (GRID:grid.411143.2) (ISNI:0000 0000 8674 9741); Konyang University, Myunggok Medical Research Institute, College of Medicine, Daejeon, Republic of Korea (GRID:grid.411143.2) (ISNI:0000 0000 8674 9741)